MedRhythms Announces an Expansion of Intellectual Property Portfolio, Securing Patent on Audio Engine for Digital Therapeutics Platform

PORTLAND, MaineApril 17, 2020 /PRNewswire/ — MedRhythms, a Portland, Maine-based company building direct stimulation digital therapeutics that use sensors, software, and music to measure and improve walking, announced today the issuance of patent US20190022351A1 by the United States Patent and Trademark Office (USPTO).

This is the second granted patent in MedRhythms’ portfolio. The patent, entitled “Enhancing Music for Repetitive Motion Activities,” covers the audio engine enabling MedRhythms’ digital therapeutics platform. Read more

Related Posts

Bar Harbor approves Jackson Lab’s $33M expansion for rare disease research

The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...

22 August 2024

Bigelow lab receives $7 million for algae research, business development

Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...

21 August 2024

Should Maine create a public medical school? UMaine System will study the question

The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...

21 August 2024